2023. Identification of RUNX1 and IFNGR2 as prognostic-related biomarkers correlated with immune infiltration and subtype differentiation of low-grade glioma. Biomolecules and Biomedicine. 23, 3 (May 2023), 405–425. DOI:https://doi.org/10.17305/bjbms.2022.8086.